Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Mirion Technologies Inc(MIR)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MIR
10/13/2026: MIR (1-star) is currently NOT-A-BUY. Pass it for now.
Mirion Technologies is a specialized provider of radiation detection and monitoring solutions for the medical and nuclear sectors. The company has a leading position in the industry, benefiting from recurring revenue in its dosimetry services and high-growth opportunities in radiation therapy QA. Its business is anchored by essential, highly regulated products, which creates durable demand. However, risks include acquisition-led integration complexity, customer concentration in government sectors, and sensitivity to nuclear policy shifts. Mirion is a potential fit for growth-oriented investors looking for exposure to clean energy and medical safety, though the absence of a dividend and potential valuation premiums warrant careful monitoring of organic growth performance.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Mirion benefits from secular trends in nuclear safety and medical radiation advancements. |
| Momentum investor | Mixed fit | Momentum is conditional on positive price trends and sustained earnings growth signals. |
| Value investor | Mixed fit | The stock valuation often commands a premium due to the company's defensive niche and market position. |
| Dividend investor | Weak fit | The company does not currently provide a dividend yield. |
| Low-risk investor | Mixed fit | While the end markets are defensive, the company's growth-through-acquisition strategy introduces integration and leverage risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | As a growth-oriented company, share prices can fluctuate based on broader market sentiment and quarterly execution. |
| Valuation risk | Medium | The stock's premium is sensitive to continued growth delivery and margin expansion. |
| Competition risk | Medium | The sector includes large, well-capitalized firms that could challenge Mirion in specific product niches. |
| Business quality | Strong | The company occupies a mission-critical, highly regulated niche that provides durable competitive advantages. |
| Dividend income | Low / none | Investors should not expect income from dividends, as capital is reinvested into the business. |
| Execution risk | Medium | Continued success depends on the effective integration of past and future acquisitions. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 42.76% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/13/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.05B USD | Price to earnings Ratio 180.56 | 1Y Target Price 24 |
Price to earnings Ratio 180.56 | 1Y Target Price 24 | ||
Volume (30-day avg) 4.1M shares | Beta 1.1 | 52 Weeks Range 14.04 - 30.28 | Updated Date 10/13/2026 |
52 Weeks Range 14.04 - 30.28 | Updated Date 10/13/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.09 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Dosimetry Services | Subscription-based radiation monitoring services for healthcare and industry. | Steady, recurring subscription revenue that provides a stable base. |
| Equipment & Systems | Sales of radiation detection and monitoring hardware. | Higher-margin project revenue linked to nuclear and medical capital spending. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 180.56 | Forward PE - | Enterprise Value 4.89B | Price to Sales(TTM) 3.95 |
Enterprise Value 4.89B | Price to Sales(TTM) 3.95 | ||
Enterprise Value to Revenue 4.77 | Enterprise Value to EBITDA 22.71 | Shares Outstanding 243.28M | Shares Floating 227.09M |
Shares Outstanding 243.28M | Shares Floating 227.09M | ||
Percent Insiders 3.42 | Percent Institutions 114.25 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.